Assessment of glycemia in diabetes mellitus: Hemoglobin A1c

Journal of Association of Physicians of India

Volumn 53, Issue APR, 2005, Pages 299-305

  Saudek, C D ^a   Kalyani, Rita R ^a   Derr, R L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; METABOLISM; REVIEW; RISK ASSESSMENT;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; RISK ASSESSMENT;

EID: 23044509686     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
2. Saudek CD, Rastogi R. Assessment of Glycemia in Diabetes Mellitus - Self-Monitoring of Blood Glucose. J Assoc Physicians India 2004;52:809-15.
3. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group. Clin Chem 1987;33:2267-71.
4. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed noninsulin dependent diabetes followed for three years [see comments]. BMJ 1995;310:83-8.
5. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969;36:838-43.
6. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417-20.
7. Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF, Gallop PM. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977;44:859-64.
8. 1: An indicator of the metabolic control of diabetic patients. Lancet 1977;2:734-7.
9. Bunn HF, Higgins PJ. Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981;213:222-4.
10. Bunn HF, Shapiro R, McManus M, et al. Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem 1979;254:3892-8.
11. Garlick RL, Mazer JS, Higgins PJ, Bunn HF. Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins. J Clin Invest 1983;71:1062-72.
12. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004;19:1175-80.
13. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 1987;10:1-19.
14. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM. Tests of glycemia in diabetes. Diabetes Care 2004;27 Suppl 1:S91-3.
15. Rohlfing C, Wiedmeyer HM, Little R, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-8.
16. Beach KW. A theoretical model to predict the behavior of glycosylated hemoglobin levels. J Theor Biol 1979;81:547-61.
17. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995;18:440-7.
18. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985-92.
19. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-63.
20. Kullberg CE, Bergstrom A, Dinesen B, et al. Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 1996;19:726-9.
21. Little RR, Wiedmeyer HM, England JD, Knowler WC, Goldstein DE. Measurement of glycosylated whole-blood protein for assessing glucose control in diabetes: collection and storage of capillary blood on filter paper. Clin Chem 1985;31:213-6.
22. Marshall SM, Home PD, Manley SE, Barth JH, John WG. Standardization of glycated haemoglobin. Diabet Med 2002;19:429.
23. O'Kane MJ, Lynch PL, Moles KW, Magee SE. Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin Chim Acta 2001;311:157-9.
24. Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200-1.
25. Mills JL, Jovanovic L, Knopp R, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism 1998;47:1140-4.
26. Lind T, Cheyne GA. Effect of normal pregnancy upon the glycosylated haemoglobins. Br J Obstet Gynaecol 1979;86:210-3.
27. Lurie S, Danon D. Life span of erythrocytes in late pregnancy. Obstet Gynecol 1992;80:123-6.
28. Parentoni LS, de Faria EC, Bartelega MJ, Moda VM, Facin AC, Castilho LN. Glycated hemoglobin reference limits obtained by high performance liquid chromatography in adults and pregnant women. Clin Chim Acta 1998;274:105-9.
29. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 1987;33:2153-63.
30. Winocour PH, Bhatnagar D, Kalsi P, Hillier VF, Anderson DC. A comparison of direct measures of glycaemia and glycated blood proteins in insulin-dependent diabetes mellitus. Clin Biochem 1989;22:457-61.
31. Lamb E, Mainwaring-Burton R, Dawnay A. Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin Chem 1991;37:2138-9.
32. Schleicher ED, Olgemoller B, Wiedenmann E, Gerbitz KD. Specific glycation of albumin depends on its half-life. Clin Chem 1993;39:625-8.
33. Cefalu WT, Bell-Farrow AD, Petty M, Izlar C, Smith JA. Clinical validation of a second-generation fructosamine assay. Clin Chem 1991;37:1252-6.
34. Narbonne H, Renacco E, Pradel V, Portugal H, Vialettes B. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes? Diabetes Metab 2001;27(5 Pt 1):598-603.
35. Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD, Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 1994;40(7 Pt 1):1317-21.
36. 1c) affected by glycemic instability? Diabetes Care 2003;26:2728-33.
37. Salardi S, Zucchini S, Santoni R, et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-4.
38. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association Cmaj 1998;159 Suppl 8:S1-29.
39. Standards of Medical Care in Diabetes. Diabetes Care 2005;28(suppl_1):S4- S36.
40. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
41. Bjork S, Kapur A, King H, Nair J, Ramachandran A. Global policy: aspects of diabetes in India. Health Policy 2003;66:61-72.
42. Raheja BS, Kapur A, Bhoraskar A, et al. DiabCare Asia - India Study: diabetes care in India - current status. J Assoc Physicians India 2001;49:717-22.
43. Chuang LM, Tsai ST, Huang BY, Tai TY. The status of diabetes control in Asia - a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med 2002;19:978-85.
44. 1c determinations. Clin Chem Lab Med 1998;36:299-308.
45. 1c) results affects metabolic control. Diabetes Care 2002;25:2110-1.
46. 1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8.